CMV retinitis: Ganciclovir/monoclonal antibody

Antiviral Research

Volumn 29, Issue 1, 1996, Pages 73-75

  Pollard, Richard B ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Cytomegalovirus; Foscarnet; Ganciclovir; Retinitis

Indexed keywords

FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; SEVIRUMAB; VIRUS ANTIBODY;

CELLULAR IMMUNITY; CLINICAL TRIAL; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMORAL IMMUNITY; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; RETINITIS;

EID: 0029867752     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00922-1     Document Type: Conference Paper

References (6)

1. SOCA in collaboration with ACTG. (1992) Mortality in patients with acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N. Eng. J. Med. 326, 213-220.
2. Rasmussen, L. et al. (1994) Deficiency in antibody response to Human Cytomegalovirus Glycoprotein gH in Human Immunodeficiency virus-infected patients at risk for Cytomegalovirus. J. Infectious Diseases 170, 673-677.
3. Lakeman, F., Blevins, B.S., Whitley, R. and Tolpin, M. (1991) in Vitro neutralization of Cytomegalovirus (CMV) strains by a human monoclonal antibody. MSL-109. Antiviral. Res. 15 (Suppl. 1), 77.
4. Nokta, M.A., Tolpin, M.D., Nadler, P.I. and Pollard, R.B. (1994) Human monoclonal anti-cytomegalovirus (CMV) antibody (MSL-109): Enhancement of in vitro foscarnet and ganciclovir induced inhibition of CMV replication. Antiviral. Res. 24, 17-26.
5. Pollard, R.B., Nokta, M.A. et al. (1992) An anti-cytomegalovirus human monoclonal antibody in individuals with AIDS: A phase I/II study. Antiviral. Res. 16 (Suppl. 1), 111.
6. Tolpin, M., Pollard, R., Tierney, M., Nokta, M., Wood, D. and Hirsch, M. (1993) Combination therapy of cytomegalovirus (CMV) retinitis with a human monoclonal antibody (SDZ MAL 109) and either ganciclovir (DHPG) or foscarnet (PFA). IXth International Conf on AIDS.